What does CUSIP 60468T905 represent in this 13F holders report?

CUSIP 60468T905 is the security identifier for 60468T905 - MIRATI THERAPEUTICS INC - COM - Call used to aggregate holder disclosures.

How many institutions held 60468T905 - MIRATI THERAPEUTICS INC - COM - Call in Q2 2022?

No institutional holders were reported for 60468T905 - MIRATI THERAPEUTICS INC - COM - Call in Q2 2022; review adjacent reporting periods for trend context.

MIRATI THERAPEUTICS INC - COM - Call

CUSIP: 60468T905

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COM
Price per share: $67.13
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 60468T905?
CUSIP 60468T905 identifies 60468T905 - MIRATI THERAPEUTICS INC - COM - Call in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 60468T905:

Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022

MIRATI THERAPEUTICS INC - COM - Call

Q2 2022 13F Holders as of 30 Jun 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of MIRATI THERAPEUTICS INC - COM - Call as of Q2 2022.